Ropinirole 24-hour prolonged release improves disease-specific and global symptoms when used as adjunctive therapy to L-dopa in patients with advanced Parkinson's disease

Authors
Category Primary study
JournalMovement Disorders
Year 2006

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
Loading references information
This article has no abstract
Epistemonikos ID: 44735f63e29f8d8fa534fd824e374d2c0cd4ceb3
First added on: Apr 19, 2017